JOIN NOW!

Enlarge Page:


Become a Member. Learn How >

Current Controversies in Healthcare

Jim Mannion, PhD, and Donald Hill, PharmD

The current political debate about healthcare financing acts as a background for this program, which will be conducted as a “point-counterpoint” discussion between panelists and members of the audience. The development and regulation of new and approved drugs falls primarily under the purview of the pharmaceutical industry and the Food and Drug Administration, respectively. Don Hill and Jim Mannion are experienced pharmaceutical-industry experts, who will discuss current topics of controversy in healthcare, such as the importation of prescription drugs, state versus federal regulatory conflicts, and safety versus the cost of testing new drugs in clinical trials.

Instructor: Jim Mannion is a pharmacist, drug developer, inventor, and entrepreneur who has spent more than 30 years in various sectors of the biopharmaceutical industry. He received his PhD in Clinical Pharmacy from Purdue University and completed a post-doctoral fellowship in clinical drug research/drug development at Burroughs Wellcome/The University of North Carolina at Chapel Hill. Most recently he was founder and CEO of Galleon Pharmaceuticals, a small biotech located in the Philadelphia area.

Donald Hill is a semi-retired pharmacist. He obtained his PharmD from UCSF and completed a fellowship in clinical research with the University of Texas. He has helped establish clinical research units in academic, government, and industrial settings, and has been a principal investigator for clinical trials.

Coordinator: Steve Clarey

Course Number: OSHR-70065   Credit: 0 units

Tools

Email to a friend

Print


Upcoming Sections